- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-GSLG1/ GLG1/ CFR-1 monoclonal antibody
Anti-GSLG1/ GLG1/ CFR-1 antibody for FACS & in-vivo assay
Go to GLG1/GLG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-MP0483-Ab-1/ GM-Tg-hg-MP0483-Ab-2 | Anti-Human GLG1 monoclonal antibody | Human |
| GM-Tg-rg-MP0483-Ab-1/ GM-Tg-rg-MP0483-Ab-2 | Anti-Rat GLG1 monoclonal antibody | Rat |
| GM-Tg-mg-MP0483-Ab-1/ GM-Tg-mg-MP0483-Ab-2 | Anti-Mouse GLG1 monoclonal antibody | Mouse |
| GM-Tg-cynog-MP0483-Ab-1/ GM-Tg-cynog-MP0483-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GLG1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-MP0483-Ab-1/ GM-Tg-felg-MP0483-Ab-2 | Anti-Feline GLG1 monoclonal antibody | Feline |
| GM-Tg-cang-MP0483-Ab-1/ GM-Tg-cang-MP0483-Ab-2 | Anti-Canine GLG1 monoclonal antibody | Canine |
| GM-Tg-bovg-MP0483-Ab-1/ GM-Tg-bovg-MP0483-Ab-2 | Anti-Bovine GLG1 monoclonal antibody | Bovine |
| GM-Tg-equg-MP0483-Ab-1/ GM-Tg-equg-MP0483-Ab-2 | Anti-Equine GLG1 monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-MP0483-Ab-1/ GM-Tg-hg-MP0483-Ab-2; GM-Tg-rg-MP0483-Ab-1/ GM-Tg-rg-MP0483-Ab-2; GM-Tg-mg-MP0483-Ab-1/ GM-Tg-mg-MP0483-Ab-2; GM-Tg-cynog-MP0483-Ab-1/ GM-Tg-cynog-MP0483-Ab-2; GM-Tg-felg-MP0483-Ab-1/ GM-Tg-felg-MP0483-Ab-2; GM-Tg-cang-MP0483-Ab-1/ GM-Tg-cang-MP0483-Ab-2; GM-Tg-bovg-MP0483-Ab-1/ GM-Tg-bovg-MP0483-Ab-2; GM-Tg-equg-MP0483-Ab-1/ GM-Tg-equg-MP0483-Ab-2 |
| Products Name | Anti-GLG1 monoclonal antibody |
| Format | mab |
| Target Name | GLG1 |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | FACS/Biofunctional Antibody, Cytokine antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-GLG1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | Products Developing | Multi-species GSLG1/ GLG1/ CFR-1 VLP (virus-like particle) (Products Developing) |
| Cytokine | GM-Tg-g-MP0483-Ag-1 | golgi glycoprotein 1 (GLG1) protein |
Target information
| Target ID | GM-MP0483 |
| Target Name | GLG1 |
| Gene ID | 2734,20340,29476,710037,479654,101095628,281196,100055066 |
| Gene Symbol and Synonyms | CFR,CFR-1,ESL-1,GLG1,MG-160,MG160,Selel |
| Uniprot Accession | Q92896,Q62638 |
| Uniprot Entry Name | GSLG1_HUMAN,GSLG1_RAT |
| Protein Sub-location | Transmembrane Protein |
| Category | Cytokine Target |
| Disease | N/A |
| Gene Ensembl | ENSG00000090863 |
| Target Classification | N/A |
The target: GLG1, gene name: GLG1, also named as CFR-1, ESL-1, MG-160, MG160. Predicted to enable fibroblast growth factor binding activity. Predicted to act upstream of or within several processes, including negative regulation of protein processing; negative regulation of transforming growth factor beta receptor signaling pathway; and regulation of chondrocyte differentiation. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
